PremaLabs Diagnostic devices use the advanced method of time-resolved fluorescence immunoassay (TRFIA) for the in-vitro quantitative detection of biomarkers.
Higher throughput usage as it reads eight different tests at once
Portable usage with a 10-hour battery life
Mobile usage with 4G connectivity and storage of 50,000 test readings
Global CEO
Joelle is a co-founder of PremaLabs diagnostics and she also covers the position of CEO of Sicania Labs where she developed deep knowledge of the medical trading arena. She brings her experience and global network into the development of PremaLabs across the international markets. Her past responsibilities and experience span the fields of finance, real estate, government relations and commodity trading.
Chief Operating Officer
Eric has spent over 20 years growing and transforming businesses across a variety of sectors and leading multi-million dollar change projects in over 30 different countries. A graduate of London Business School, Eric has worked with over a dozen businesses, from small start-ups to large conglomerates such as Time Warner and P&G and was a member of the Operational Turnaround team for private equity firm Terra Firma Capital Partners during their $4.7b takeover of EMI Music. Later in his career, as SVP of International Business Transformation for The Interpublic Group of Companies, Eric helped improve underperforming business units across the company’s 65,000 person network and led operations for teams working with clients such as Pfizer, J&J and Coca Cola. At PremaLabs, Eric is focused on the strategic development and market entry within the United Kingdom and building the operations to support these activities.
Founding Partner & International Business Development
Adriano Zuccala is one of the leading experts in the field of point-of-care diagnostics and international business development. As a founding partner of Premalabs Diagnostic, he has helped to make the company a global player in the diagnostics industry.
His achievements in the point-of-care field in Germany, England, and Poland are impressive. Under his leadership, Premalabs Diagnostic has formed strategic partnerships with leading companies in the industry and developed innovative solutions that are revolutionizing the healthcare sector. Thanks to his visionary leadership, the company has achieved significant growth rates and expanded its presence on an international level.
Adriano Zuccala has an impressive international network and speaks several languages fluently, including German, English, Italian, and Polish. These skills have helped him to build successful business relationships all over the world and promote the growth of Premalabs Diagnostic.
In addition to his leadership role at Premalabs Diagnostic, Adriano Zuccala is also actively involved in the industry. He has given numerous lectures and is a respected expert at conferences and events. Overall, Adriano Zuccala has made a significant contribution to the advancement of point-of-care diagnostics and is a recognized expert in the industry.
Chief Commercial Officer
Adam is an experienced commercial leader with over 20 years experience working globally across start up and market leading companies within Diagnostics, Pharmaceuticals, Medical Device, and SaaS companies most notably MSD, Abbott, LivaNova and Coloplast. He has built numerous sales and marketing teams and his strategic acumen combined with creative marketing enables him to devise and implement plans which drive revenue and enable companies to make a difference to the patients and physicians they serve. Passionate about the world of point of care testing since his time at Abbott, Adam has built a strong network of contacts and advocates globally with the aim of making point of care accessible to all patients who deserve and require immediate test results.
Chief Clinical Officer
Annie was awarded the MBE in 2018 for her services to healthcare export, health transformation and the delivery of services throughout China, Asia, and the UK. Recently, Annie provided COVID testing with Immunofluorescence Chromatography devices and provided essential training throughout the pandemic. A graduate of Oxford University Said Business School, she was recruited by Goldman Sachs, to run their fast-track business programme. Working with government agencies in the UK such as Healthcare UK, Department of International Trade (DIT) she is also a founder member of UK International Healthcare Management Association (UKHIMA). As an international expert, speaker, strategist and thought leader behind many innovative projects for improving patient care via training, technology, digital health, and workforce development Annie’s passion is to transform patient care through service development and training. Annie is the Winner Most Inspiring Female Business Leader (Global) 2021
Chief Technology Officer
Leon’s expertise extends to the areas of instrumentation and biotechnology. Prior to joining the company, Leon worked in the Oil and Gas sector at the Oktan Group, where he helped develop and implemented business process optimisations and automation solutions. Leon is responsible for the technical oversight of the company and the development of the company IT strategy. In particular, he is focused on the development and commercialization of emerging technologies.
Founding Partner & Business Development Global
Andrea is a serial entrepreneur, having experience in forming global consultancies and trading companies in a wide range of industries. He a co-founder of Sicania Labs and leads a team which source a broad range of medical related supplies and equipment in extreme supply conditions, ensuring a steady provision to healthcare professionals and institutions globally. Andrea is customer oriented, a team player and brings his management skills and extensive global network of high-level contacts to PremaLabs. As a problem solver, Andrea has a clear focus on creating sustainable value propositions and opportunities that align to the vision of PremaLabs and its technologies.
Strategic Advisor
Ian jointly heads up a health sector consulting business that delivered over $6bn of health care projects since formation. They undertake through-the-line (policy-strategy-mobilisation) clinical and commercial assignments in the UK, US and Middle East for commissioning, provider and insurance clients. They developed and implemented national strategies and created innovative new care pathways encouraging the formation of newcos, vertical integration and collaboration between public and private sector organisations to deliver patient centred services. His teams have designed and implemented: UCCs at the front of leading London A&Es; created PPU partnerships between NHS and private providers.
